instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news
RAHWAY, NJ / ACCESSWIRE / November 20, 2024 / The Merck Foun
Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care | Morningstar
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
Payden & Rygel Grows Position in Merck & Co., Inc. (NYSE:MRK)
Moran Wealth Management LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Grandfield & Dodd LLC
Commerce Bank Buys 29,422 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Stake Cut by Northwest Bancshares Inc.
Strategy Asset Managers LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Prospera Private Wealth LLC Buys 12,781 Shares of Merck & Co., Inc. (NYSE:MRK)
Quest Partners LLC Has $1.18 Million Stake in Merck & Co., Inc. (NYSE:MRK)
J&J, Merck Cut Jobs in China as Local Competition Takes Toll
Merck & Co., Inc. (NYSE:MRK) Raises Dividend to $0.81 Per Share
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.1% - Here's Why
Prospera Financial Services Inc Purchases 9,387 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Boosted by Smead Capital Management Inc.
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Meeder Asset Management Inc.
Belmont Capital LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK)
Merck's Phase 3 Study Of Subcutaneous Keytruda To Treat NSCLC Meets Primary Goals
Pathstone Holdings LLC Sells 7,059 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation | Morningstar
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 0.6% – Should You Sell?
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.6% - What's Next?
Mendel Capital Management LLC Lowers Position in Merck & Co., Inc. (NYSE:MRK)
Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now?
Braun Stacey Associates Inc. Lowers Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
AMG National Trust Bank Sells 5,505 Shares of Merck & Co., Inc. (NYSE:MRK)
Aljian Capital Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by TrinityPoint Wealth LLC
Swiss National Bank Boosts Stake in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Thrivent Financial for Lutherans
Mutual of America Capital Management LLC Decreases Stake in Merck & Co., Inc. (NYSE:MRK)
Mizuho Securities USA LLC Sells 53,617 Shares of Merck & Co., Inc. (NYSE:MRK)
Cutler Investment Counsel LLC Sells 3,127 Shares of Merck & Co., Inc. (NYSE:MRK)
Natixis Advisors LLC Lowers Stake in Merck & Co., Inc. (NYSE:MRK)
Kentucky Retirement Systems Has $20.05 Million Stake in Merck & Co., Inc. (NYSE:MRK)
Intellectus Partners LLC Acquires Shares of 6,426 Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Down 2.4% - Here's What Happened
Linscomb Wealth Inc. Has $8.11 Million Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Earns Peer Perform Rating from Analysts at Wolfe Research
Signature Estate & Investment Advisors LLC Raises Stake in Merck & Co., Inc. (NYSE:MRK)
GenScript Subsidiary ProBio Instrumental in Latest Fight Against Cancer | Morningstar
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Birchcreek Wealth Management LLC
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Archer Investment Corp
Empowered Funds LLC Buys 147,267 Shares of Merck & Co., Inc. (NYSE:MRK)
Wolfe Research Initiates Coverage on Merck & Co., Inc. (NYSE:MRK)
Dearborn Partners LLC Reduces Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by CIBC Asset Management Inc
Merck Gets CHMP Backing of Keytruda in Malignant Pleural Mesothelioma | Morningstar
EU committee endorses Merck's KEYTRUDA for mesothelioma treatment By Investing.com
4,291 Shares in Merck & Co., Inc. (NYSE:MRK) Acquired by Versor Investments LP
Merck & Co., Inc. (NYSE:MRK) Cut to Neutral at Daiwa Capital Markets
Merck licenses Lanova’s PD-1/VEGF bispecific in $2.7B+ deal | BioWorld
Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy - November 15, 2024 - Zacks.com
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 0.3% - Time to Sell?
Omnia Family Wealth LLC Has $408,000 Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by ING Groep NV
Lifeworks Advisors LLC Boosts Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Curi RMB Capital LLC Sells 22,942 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck in Cancer Licensing Pact With LaNova Medicines | Morningstar
Merck Expands Oncology Pipeline By Securing License For LaNova Medicines' LM-299 | Markets Insider
Merck Snags Chinese Cancer Drug For Up to $3.3 Billion
12,709 Shares in Merck & Co., Inc. (NYSE:MRK) Bought by GSA Capital Partners LLP
Merck snags Chinese cancer drug for up to US$3.3 billion
Vanguard Health Care Fund - Vanguard Health Care Fund Portfolio Update (portfolio as of ...
Kimberly-Clark Elects Joseph Romanelli to its Board of Directors | Morningstar
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.4% - Should You Sell?
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Main Street Financial Solutions LLC
Syros slammed by phase III data with tamibarotene in MDS | BioWorld
Oppenheimer & Co. Inc. Buys 6,503 Shares of Merck & Co., Inc. (NYSE:MRK)
TileDB Powers Multiomics Research: Now Trusted by Half of Top Global Pharma Giants | Morningstar
Pinnacle Financial Partners Inc Grows Stock Position in Merck & Co., Inc. (NYSE:MRK)
Haverford Trust Co Sells 54,165 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Lessened by Buck Wealth Strategies LLC
Merck & Co., Inc. (NYSE:MRK) Shares Down 1% - Time to Sell?
Victory Capital Management Inc. Grows Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Aptus Capital Advisors LLC Buys 43,852 Shares of Merck & Co., Inc. (NYSE:MRK)
Prime Capital Investment Advisors LLC Increases Stake in Merck & Co., Inc. (NYSE:MRK)
Ashton Thomas Private Wealth LLC Sells 7,904 Shares of Merck & Co., Inc. (NYSE:MRK)
Sumitomo Mitsui Trust Group Inc. Boosts Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Downgraded to “Hold” Rating by Daiwa America
Merck & Co., Inc. (NYSE:MRK) Downgraded to "Hold" Rating by Daiwa America
OVERSEA CHINESE BANKING Corp Ltd Cuts Stake in Merck & Co., Inc. (NYSE:MRK)
Entropy Technologies LP Has $4.52 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK)
Apollon Wealth Management LLC Sells 5,538 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Down 1.4% - Here's Why
tru Independence LLC Sells 486 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Migdal Insurance & Financial Holdings Ltd.
Merck & Co., Inc. (NYSE:MRK) Downgraded by Daiwa Capital Markets to Neutral
Chartwell Investment Partners LLC Trims Stake in Merck & Co., Inc. (NYSE:MRK)
14,161 Shares in Merck & Co., Inc. (NYSE:MRK) Purchased by Kennebec Savings Bank
Assetmark Inc. Has $16.71 Million Position in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Los Angeles Capital Management LLC
Stockman Wealth Management Inc. Purchases 6,375 Shares of Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Crossmark Global Holdings Inc.
Privium Fund Management B.V. Increases Holdings in Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Mesirow Financial Investment Management Inc.